- Home
- CDTX vs BLFY Comparison
CDTX vs BLFY Comparison
Compare CDTX & BLFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- BLFY
- Stock Information
- Founded
- CDTX 2012
- BLFY 1939
- Country
- CDTX United States
- BLFY United States
- Employees
- CDTX N/A
- BLFY N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- BLFY Commercial Banks
- Sector
- CDTX Health Care
- BLFY Finance
- Exchange
- CDTX Nasdaq
- BLFY Nasdaq
- Market Cap
- CDTX 259.0M
- BLFY 217.6M
- IPO Year
- CDTX 2015
- BLFY N/A
- Fundamental
- Price
- CDTX $17.82
- BLFY $8.81
- Analyst Decision
- CDTX Strong Buy
- BLFY Hold
- Analyst Count
- CDTX 8
- BLFY 2
- Target Price
- CDTX $38.00
- BLFY $11.00
- AVG Volume (30 Days)
- CDTX 156.0K
- BLFY 50.2K
- Earning Date
- CDTX 05-14-2025
- BLFY 04-23-2025
- Dividend Yield
- CDTX N/A
- BLFY N/A
- EPS Growth
- CDTX N/A
- BLFY N/A
- EPS
- CDTX N/A
- BLFY N/A
- Revenue
- CDTX $1,275,000.00
- BLFY $40,694,000.00
- Revenue This Year
- CDTX N/A
- BLFY $13.64
- Revenue Next Year
- CDTX N/A
- BLFY $21.23
- P/E Ratio
- CDTX N/A
- BLFY N/A
- Revenue Growth
- CDTX N/A
- BLFY N/A
- 52 Week Low
- CDTX $10.00
- BLFY $7.90
- 52 Week High
- CDTX $28.42
- BLFY $11.48
- Technical
- Relative Strength Index (RSI)
- CDTX 33.85
- BLFY 31.64
- Support Level
- CDTX $19.83
- BLFY $8.93
- Resistance Level
- CDTX $23.76
- BLFY $9.23
- Average True Range (ATR)
- CDTX 1.58
- BLFY 0.23
- MACD
- CDTX -0.53
- BLFY -0.02
- Stochastic Oscillator
- CDTX 5.11
- BLFY 6.76
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About BLFY Blue Foundry Bancorp
Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.